Trusted microarray analysis for uncompromised results

Chromosomal abnormalities and genomic instability are some of the most important aberrations in malignancies. Thermo Fisher Scientific offers advanced microarray solutions that are designed to provide comprehensive coverage and the highest resolution, so you do not miss important aberrations.


Optimize cancer sample profiling with a single assay that provides whole genome coverage to help advance oncology genetic research in your laboratory.  


Customer & solutions overview

Raise your productivity to a whole new level

Hip Hip array! The new CytoScan Cytogenetics Suite with a two-day turnaround time, improved coverage, and automated interpretation and reporting capabilities is now available.

Overcoming today's lab challenges with CytoScan HD Accel

Dr. Debbie Black discusses the substantial advancements the new CytoScan HD Accel Array brings such as, two-day turnaround time, improved probe coverage, a new reference model that allows users to obtain more pertinent insights in less time compared to the currently dominant microarray in the market, boosting lab productivity by up to 100%.

Application of CMA in oncology

Dr. Sukhanova demonstrates how combining chromosomal microarray analysis (CMA) with next-generation sequencing (NGS) assays helps to identify genetic aberrations in different types of cancer.

Analyzing karyotypes in hematological malignancies are critical

Added precision to molecular karyotyping analysis is fast becoming the standard for detecting chromosomal aberrations in leukemias. 

Enhance efficiency and productivity in cytogenetic analysis with the CytoScan HD Accel Suite

The informative white paper examines the obstacles in efficiency and productivity that laboratories face when striving to deliver reliable and reproducible results. The all new Applied Biosystems CytoScan HD Accel Suite is designed to help overcome these obstacles.

Copy number analysis of FFPE samples with OncoScan assays

The OncoScan assays enable accurate analysis of copy number changes and allelic imbalances across the entire genome. These assays have been shown to perform well with highly degraded DNA, such as that derived from FFPE tumor samples.

CytoScan arrays




Chromosome Analysis Suite (ChAS) Software




© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.